Cyclacel Pharmaceuticals, Inc. (CYCC) Stock Ratings

View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:

Not Rated

No Current Ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks

Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
jtseowh jtseowh 11/28/2015 3 months $1.02 $0.36 -65.2% 65 Ended
NotRequired NotRequired 03/06/2015 1 month $1.03 $0.87 -15.54% -15 Ended
Sebastiaan Sebastiaan 08/27/2014 3 months $3.48 $2.98 -14.37% -14 Ended
Comments: in critical development test phase, short term upcoming catalysts
matrix_man matrix_man 09/10/2013 3 months $3.39 $4.79 +41.3% 41 Ended
Comments: Another The Rule Of 32
JOKER66 JOKER66 12/10/2012 1 week $6.45 $6.30 -2.33% -2 Ended
J Dupont III J Dupont III 06/07/2012 3 months $0.49 $3.36 +585.71% 585 Ended
Comments: Upcoming product launch will be successful
karol_1 karol_1 12/29/2010 1 Year $1.51 $0.59 -60.93% -60 Ended
Comments: Projecting strong long-term growth
boomer_1 boomer_1 10/13/2010 3 months $1.70 $0.59 -65.3% -65 Ended
Comments: Projecting strong long-term growth
SLRtrades SLRtrades 05/06/2010 3 months N/A Ended
Comments: ,Great potential PPS increase after SPA approval.
CeeDee CeeDee 02/03/2010 3 months N/A Ended
Comments: ...the pullback is done. Soon it will be 3 $. You'll see
Miro_1 Miro_1 01/12/2010 3 months N/A Ended

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.